Literature DB >> 3603029

The fragile X site in somatic cell hybrids: an approach for molecular cloning of fragile sites.

S T Warren, F Zhang, G R Licameli, J F Peters.   

Abstract

Fragile X syndrome is a common form of mental retardation associated with a fragile site on the human X chromosome. Although fragility at this site is usually evident as a nonstaining chromatid gap, it remains unclear whether or not actual chromosomal breakage occurs. By means of somatic cell hybrids containing either a normal human X or a fragile X chromosome and utilizing two genes that flank the fragile site as markers of chromosome integrity, segregation of these markers was shown to be more frequent if they encompass the fragile site under appropriate culture conditions. Hybrid cells that reveal marker segregation were found to contain rearranged X chromosomes involving the region at or near the fragile site, thus demonstrating true chromosomal breakage within this area. Two independent translocation chromosomes were identified involving a rodent chromosome joined to the human X at the location of the fragile site. DNA analysis of closely linked, flanking loci was consistent with the position of the breakpoint being at or very near the fragile X site. Fragility at the translocation junctions was observed in both hybrids, but at significantly lower frequencies than that seen in the intact X of the parental hybrid. This observation suggests that the human portion of the junctional DNA may contain part of a repeated fragility sequence. Since the translocation junctions join heterologous DNA, the molecular cloning of the fragile X sequence should now be possible.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3603029     DOI: 10.1126/science.3603029

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  41 in total

1.  Increased genetic instability of the common fragile site at 3p14 after integration of exogenous DNA.

Authors:  F V Rassool; M M Le Beau; M E Neilly; E van Melle; R Espinosa; T W McKeithan
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

Review 2.  Small insertions and deletions (INDELs) in human genomes.

Authors:  Julienne M Mullaney; Ryan E Mills; W Stephen Pittard; Scott E Devine
Journal:  Hum Mol Genet       Date:  2010-09-21       Impact factor: 6.150

3.  Structural and transcriptional analysis of a human subtelomeric repeat.

Authors:  J F Cheng; C L Smith; C R Cantor
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

4.  Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites.

Authors:  F V Rassool; T W McKeithan; M E Neilly; E van Melle; R Espinosa; M M Le Beau
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

Review 5.  The fragile X: progress toward solving the puzzle.

Authors:  W T Brown
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

6.  In situ hybridization to cytogenetic bands of yeast artificial chromosomes covering 50% of human Xq24-Xq28 DNA.

Authors:  V Montanaro; A Casamassimi; M D'Urso; J Y Yoon; W Freije; D Schlessinger; M Muenke; R L Nussbaum; S Saccone; S Maugeri
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

7.  Characteristic chromosomal fragility of human embryonic cells exposed in vitro to aphidicolin.

Authors:  D Caporossi; P Vernole; B Nicoletti; B Tedeschi
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

Review 8.  Anticipation in hereditary disease: the history of a biomedical concept.

Authors:  Judith E Friedman
Journal:  Hum Genet       Date:  2011-06-12       Impact factor: 4.132

9.  Profile of Stephen T. Warren.

Authors:  Jennifer Viegas
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

10.  Fluorescent in-situ hybridization of cattle and sheep chromosomes with cloned human fragile-X DNA.

Authors:  Ahmad Ali; P D Thomsen; M E Babar
Journal:  Mol Biol Rep       Date:  2008-03-14       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.